Merck & Co., Inc. president Richard R. DeLuca sells $8.61M of MRK
The sale reduces the insider's holding by 34%, the filing shows.
Richard R. DeLuca sold about $8.6 million of Merck & Co., Inc. (MRK) stock on Nov 12, according to an SEC filing. The president received an average of $148.01 for 58,185 shares.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. After the trade, the filing lists 112,955 shares held.
No other open-market sale at Merck & Co., Inc. was reported in the previous 90 days. The filing came 4 days after the trade.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Merck & Co., Inc. (MRK) |
|---|---|
| Insider | Richard R. DeLuca |
| Role | President |
| Transaction | Open-market sale (code S) |
| Shares | 58,185 |
| Average price | $148.01 |
| Value | $8,611,875 |
| Trade date | Nov 12, 2026 |
| Filed with the SEC | Nov 16, 2026, 4:19 PM ET |
| Shares held after | 112,955 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See more details on this insider sale
Follow MRK for the next insider trade · Browse the latest insider selling
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.